Insider buys and sells (Form 4)
Mineralys Therapeutics, Inc. insiders: buys and sells · MLYS
Directors, officers and 10%+ shareholders must report every purchase and sale of their company's stock to the SEC within two business days. Transactions filed between 2026-09-30 and 2026-09-30. All filings on SEC EDGAR →
- Bought
- $0
- Sold
- $1,909,665
- Buys
- 0
- Sells
- 1
The 1 transactions
| Date | Who | Role | Transaction | Shares | Price | Amount |
|---|---|---|---|---|---|---|
| 2026-09-30 | Congleton Jon | Chief Executive Officer | sell | 75.000 | 25,462 | $1,909,665 |
How to read these transactions
There is a single filed transaction for Mineralys Therapeutics, Inc. (MLYS), on 2026-09-30. Open-market buys: 0, for $0. Sells: 1, for $1,909,665.
Each transaction comes from a Form 4, the filing the person submits to the SEC. In the table, each row is one transaction: the date, who made it and their role, whether it is a buy or a sell, the number of shares, the declared price per share and the total amount.
Open-market buys are the ones people watch most, because whoever makes them puts in their own money. Sells say less: they often respond to taxes, diversification or sale plans scheduled in advance. A single transaction does not say much either; what people look at is whether they repeat, from how many people and for what amount.
Other companies with insider trades
monday.com Ltd. (MNDY) · MANNKIND CORP (MNKD) · MEDICINOVA INC (MNOV) · Monopar Therapeutics (MNPR) · MINISO Group Holding Ltd (MNSO) · ALTRIA GROUP, INC. (MO) · Lord Abbett Municipal Opportunities Fund (MOALX) · MOBIX LABS, INC (MOBX)
Public SEC data (EDGAR), Form 4. Open-market buys and sells only: option exercises and stock received as pay are left out. This is not investment advice.
Follow them next to your own portfolio
In Arvenyx you see these portfolios, insider buys and your own portfolio, across all your brokers, in one place.
Create a free account